Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 14 (2023)
      • Volume 14 – Issue 2
      • Volume 14 – Issue 1
      • Volume 14 – Suppl. 1
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: lipoproteins

Lipid markers, gender and cardiovascular disease; Highlights from the ATTICA prospective epidemiological study (2002-2012)

Matina Kouvari, Demosthenes B. Panagiotakos, Christina Chrysohoou, Ekavi N. Georgousopoulou, Dimitrios Tousoulis, Christos Pitsavos, The ATTICA study Investigators

Pharmacological management of nonalcoholic fatty liver disease: Limitations, challenges and new therapeutic opportunities

Eleni A. Karavia, Kyriakos E. Kypreos

Lipid control in patients with and without type 2 Diabetes Mellitus (T2DM). The experience of a special unit of a second grade hospital

Stamatis S Papadatos, Adamantios Bourdakis

HDL as a transporter of microRNAs in plasma: potential pathophysiolocal role

A. I. Gatsiou, K. Stellos, A. D. Tselepis

CURRENT ISSUE

Apolipoprotein A2 reduces the levels of circulating triglyceride-rich lipoproteins, an effect blocked by apolipoprotein E
The synergistic effect of EPA and DHA with cyclooxygenase-1 inhibitors on platelet aggregation
Association between screen-time use and cardiometabolic-related lifestyle characteristics, in Greek young adults
Obesity is a disease: A Consensus Report by the Alliance to Fight Obesity in Greece

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (4) cardiovascular disease (25) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (6) childhood obesity (3) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes mellitus (9) diet (6) dyslipidemia (14) empagliflozin (3) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (8) inflammation (10) lipoproteins (4) longevity (3) Mediterranean diet (8) metabolic syndrome (7) morbidity (3) mortality (8) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (9) PCSK9 (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombin (3) thrombosis (4) treatment (5) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2023
A SiteOrigin Theme